Importantly, IFN-γ priming of monocytes from PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome patients induces a pyrin-dependent IL-18 release and JAK inhibitors have a beneficial effects on the skin lesions of these patients.31 This evidence concerns the gene IFNG and pyoderma gangrenosum.